Evidence map›Paper›PMID 35276764›Full record

Trial reportNutrients2022

Effects of an Optimized Aged Garlic Extract on Cardiovascular Disease Risk Factors in Moderate Hypercholesterolemic Subjects: A Randomized, Crossover, Double-Blind, Sustainedand Controlled Study.

Rosa M Valls, Judit Companys, Lorena Calderón-Pérez, Patricia Salamanca, Laura Pla-Pagà, Berner Andrée Sandoval-Ramírez, Antonio Bueno, Jose Puzo, Anna Crescenti, Josep M Del Bas and 6 more

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
7.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Effects of aged black garlic (ABG10+Frontiers in nutrition · 2026
    Trial
  4. Trial
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Rosa M VallsFunctional Nutrition, Oxidation and Cardiovascular Diseases Group (NFOC-Salut), Facultat de Medicina i Ciències de la Salut, Universitat Rovira i Virgili, C/Sant Llorenç, 21, 43201 Reus, Spain.ORCID 0000-0002-3351-0942
Judit CompanysEurecat, Centre Tecnològic de Catalunya, Unitat de Nutrició i Salut, Av/de la Universitat, 1, 43204 Reus, Spain.ORCID 0000-0003-1485-0818
Lorena Calderón-PérezEurecat, Centre Tecnològic de Catalunya, Unitat de Nutrició i Salut, Av/de la Universitat, 1, 43204 Reus, Spain.
Patricia SalamancaFunctional Nutrition, Oxidation and Cardiovascular Diseases Group (NFOC-Salut), Facultat de Medicina i Ciències de la Salut, Universitat Rovira i Virgili, C/Sant Llorenç, 21, 43201 Reus, Spain.ORCID 0000-0002-9606-6762
Laura Pla-PagàEurecat, Centre Tecnològic de Catalunya, Unitat de Nutrició i Salut, Av/de la Universitat, 1, 43204 Reus, Spain.
Berner Andrée Sandoval-RamírezFunctional Nutrition, Oxidation and Cardiovascular Diseases Group (NFOC-Salut), Facultat de Medicina i Ciències de la Salut, Universitat Rovira i Virgili, C/Sant Llorenç, 21, 43201 Reus, Spain.
Antonio BuenoLipid Unit, Clinical Analysis and Biochemistry Service, Hospital San Jorge de Huesca, 22004 Huesca, Spain.
Jose PuzoLipid Unit, Clinical Analysis and Biochemistry Service, Hospital San Jorge de Huesca, 22004 Huesca, Spain.ORCID 0000-0002-1309-4363
Anna CrescentiEurecat, Centre Tecnològic de Catalunya, Unitat de Nutrició i Salut, Av/de la Universitat, 1, 43204 Reus, Spain.
Josep M Del BasEurecat, Centre Tecnològic de Catalunya, Unitat de Nutrició i Salut, Av/de la Universitat, 1, 43204 Reus, Spain.
Antoni CaimariEurecat, Centre Tecnològic de Catalunya, Biotechnology Area, Av/de la Universitat, 1, 43204 Reus, Spain.ORCID 0000-0001-6144-0294
Aurora SalamancaPharmactive Biotech Products, S.L., C/Faraday 7, 28049 Madrid, Spain.
Alberto E EspinelPharmactive Biotech Products, S.L., C/Faraday 7, 28049 Madrid, Spain.
Anna PedretFunctional Nutrition, Oxidation and Cardiovascular Diseases Group (NFOC-Salut), Facultat de Medicina i Ciències de la Salut, Universitat Rovira i Virgili, C/Sant Llorenç, 21, 43201 Reus, Spain.ORCID 0000-0002-5327-932X
Lluís ArolaEurecat, Centre Tecnològic de Catalunya, Unitat de Nutrició i Salut, Av/de la Universitat, 1, 43204 Reus, Spain.ORCID 0000-0003-2767-1974
Rosa SolàFunctional Nutrition, Oxidation and Cardiovascular Diseases Group (NFOC-Salut), Facultat de Medicina i Ciències de la Salut, Universitat Rovira i Virgili, C/Sant Llorenç, 21, 43201 Reus, Spain.
Technological Center of Nutrition and Health · ESDepartament de Salut · ESHospital General San Jorge · ES

Funding

Centre for the Development of Industrial Technology (CDTI) of the Spanish Ministry of Science and Innovation, grant number. EXP 00109491/IDI-20180389
6 · The paper itself

Abstract

The consumption of aged black garlic (ABG) has been related to improvements in several cardiovascular disease (CVD) risk factors. However, the extent of the beneficial effects depends on the garlic aging process and the amount and type of chemical compounds accumulated. The main objective of this study was to assess the effect of daily intake of a well-characterized ABG extract with a standardized S-allyl-L-cysteine (SAC) yield in combination with dietary recommendations regarding CVD risk factors in individuals with moderate hypercholesterolemia. Sixty-seven hypercholesterolemic individuals with low-density lipoprotein cholesterol levels ≥115 mg/dL were randomized in a crossover, double-blind, sustained, and controlled intervention study. The participants consumed 250 mg (1.25 mg SAC)/tablet/day ABG or a placebo for 6 weeks, with 3 weeks of washout. Blood and pulse pressure and other CVD risk biomarkers were determined at the beginning and end of each intervention. At 6 weeks, ABG extract reduced diastolic blood pressure (DBP) (mean (95% CI) −5.85 (−10.5; −1.3) mm Hg) compared to the placebo, particularly in men with a DBP > 75 mm Hg. The consumption of an improved ABG extract with 1.25 mg of SAC decreased DBP, particularly in men with moderate hypercholesterolemia. The potential beneficial effects of ABG may contribute to obtaining an optimal DBP.

Indexed as

Cardiovascular DiseasesGarlicAgedCross-Over StudiesHumansMalePlant ExtractsRisk FactorsPlant Extractsaged garlic extractblood pressurecardiovascular disease risk factorhypercholesterolemiapulse pressureS-allyl-L-cysteine

Identifiers

PMID35276764
PMCPMC8838962
OpenAlexW4206053781

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.